ロード中...
Ageing is a risk factor in imatinib mesylate cardiotoxicity
AIMS: Chemotherapy-induced heart failure is increasingly recognized as a major clinical challenge. Cardiotoxicity of imatinib mesylate, a highly selective and effective anticancer drug belonging to the new class of tyrosine kinase inhibitors, is being reported in patients, some progressing to conges...
保存先:
| 出版年: | Eur J Heart Fail |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4238824/ https://ncbi.nlm.nih.gov/pubmed/24504921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.58 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|